Drug Information

Drug General Information
Drug ID
D07BQN
Former ID
DNC009862
Drug Name
N-(3,3-Diphenyl-propyl)-2-pyridine-3-ylacetamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530375]
Structure
Download
2D MOL

3D MOL
Formula
C22H22N2O
Canonical SMILES
C1=CC=C(C=C1)C(CCNC(=O)CC2=CN=CC=C2)C3=CC=CC=C3
InChI
1S/C22H22N2O/c25-22(16-18-8-7-14-23-17-18)24-15-13-21(19-9-3-1-4-10-19)20-11-5-2-6-12-20/h1-12,14,17,21H,13,15-16H2,(H,24,25)
InChIKey
FNEXDTNOFQXKRJ-UHFFFAOYSA-N
PubChem Compound ID
11976254
Target and Pathway
Target(s) Soluble epoxide hydrolase Target Info Inhibitor [530375]
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
Peroxisome
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Metapathway biotransformation
Arachidonate Epoxygenase / Epoxide Hydrolase
Arachidonic acid metabolism
References
Ref 530375J Med Chem. 2009 Oct 8;52(19):5880-95.Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.
Ref 530375J Med Chem. 2009 Oct 8;52(19):5880-95.Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.